Dimensional Fund Advisors’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$54.8K Hold
4,351
– – ﹤0.01% 3184
2026
Q2
$60.3K Hold
4,351
– – ﹤0.01% 3180
2026
Q1
$77.5K Hold
4,351
– – ﹤0.01% 3137
2025
Q4
$121K Hold
4,351
– – ﹤0.01% 3133
2025
Q3
$173K Sell
4,351
-100
-2% -$4.06K ﹤0.01% 3136
2025
Q2
$170K Hold
4,451
– – ﹤0.01% 3136
2025
Q1
$119K Hold
4,451
– – ﹤0.01% 3183
2024
Q4
$142K Sell
4,451
-623
-12% -$19.6K ﹤0.01% 3199
2024
Q3
$146K Hold
5,074
– – ﹤0.01% 3205
2024
Q2
$195K Sell
5,074
-247
-5% -$13.9K ﹤0.01% 3170
2024
Q1
$472K Sell
5,321
-56
-1% -$3.64K ﹤0.01% 3054
2023
Q4
$334K Sell
5,377
-10,499
-66% -$788K ﹤0.01% 3109
2023
Q3
$1.91M Sell
15,876
-20,176
-56% -$2.83M ﹤0.01% 2796
2023
Q2
$6.04M Buy
36,052
+24,620
+215% +$5.12M ﹤0.01% 2462
2023
Q1
$2.89M Buy
+11,432
New +$2.64M ﹤0.01% 2643

Other funds holding SKIN

Dimensional Fund Advisors's SKIN Position: Q3 2026 in Review

Dimensional Fund Advisors held its SkinHealth Systems (SKIN) position steady in Q3 2026 at 4,351 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3184.

Dimensional Fund Advisors first reported a position in SKIN in Q1 2023 and has held it in 15 quarters since. The position peaked at $6.04M in Q2 2023. 47 funds tracked by Wall St. Rank hold SKIN as of Q3 2026.

  • Dimensional Fund Advisors held 4,351 shares of SkinHealth Systems worth $54.8K as of Q3 2026.
  • Dimensional Fund Advisors left its SkinHealth Systems share count unchanged in Q3 2026.
  • SkinHealth Systems made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #3184 holding.
  • Dimensional Fund Advisors first reported a position in SkinHealth Systems in Q1 2023 and has held it in 15 quarters since.
  • Dimensional Fund Advisors's SkinHealth Systems position peaked at $6.04M in Q2 2023.
  • 47 funds tracked by Wall St. Rank held SkinHealth Systems as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.